trastuzumab deruxtecan
daiichi sankyo,astrazeneca
['trastuzumab deruxtecan', 'breast', '217o']
#esmo22 abstract 217o: based on pre-defined patient reported outcome measures, researchers found that treatment with trastuzumab deruxtecan delays the decline of quality of life in patients with her2 low metastatic breast cancer: #endcancer
MD Anderson is a global leader in cancer care, research, education and training, and prevention. Appointments available: 1-877-632-6789